Gene Biotherapeutics
(OTC) CRXM
Gene Biotherapeutics Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$0.00
Net Income (TTM)
$518.35K
EPS (TTM)
N/A
P/E Ratio
N/A
Dividend
N/A
Beta (Volatility)
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
CRXM News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Gene Biotherapeutics
CRXM Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
13%
Return on Capital
28%
Return on Assets
-91%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Short Interest
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$1.82K
Operating Income
$1.26M
EBITDA
$1.26M
Operating Cash Flow
$1.13M
Capital Expenditure
$3.43K
Free Cash Flow
$1.14M
Cash & ST Invst.
$386.03K
Total Debt
$1.26M
Gene Biotherapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonCurrently no data to display.
Quarterly Performance
Revenue
$0.00
N/A
Gross Profit
$0.00
N/A
Gross Margin
0.00%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
3
N/A
Net Income
$443.00K
-130.6%
EBITDA
$476.00K
-132.7%
Quarterly Fundamentals
Net Cash
$874.44K
+22.0%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$107.89K
-11.7%
Short Term Debt
$1.15M
+15.4%
Return on Assets
-91.36%
N/A
Return on Invested Capital
28.29%
N/A
Free Cash Flow
$337.87K
-1344.4%
Operating Cash Flow
$337.87K
-1344.4%